BioMarin Pharmaceutical Inc.

BMRN.VI·Vienna·Healthcare
Compare
51.14+0.46 (+0.91%)today
As of Nov 5, 1:00 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close50.68
Open51.38
Day range51.1052.18
52-week range42.7761.40
Off day high−1.99%
Off 52-week high−16.71%
Volume279
Avg. volume (3M)150
Market cap9.91B
EPS (TTM)-0.0900
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.23
Shares outstanding193.69M
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin−0.52%

Against its peers

Compare in full ›
BMRN.VI BBIO 1952.HK IONS 0NZU.IL KRYS
Market cap 9.91B 15.17B 9.83B 6.67B 14.40B 9.21B
P/E (TTM) — — — — — 42.2
Forward P/E — -225.0 20.4 -35.0 — 34.0
Price/book 1.8 -5.9 1.3 15.1 8.1 6.4
Dividend yield — — — — — —
1-year change +12.30% +24.17% −44.53% −45.82% −43.38% +55.44%
Today +0.91% +5.21% +5.06% −0.67% +1.34% +1.90%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All BMRN.VI news ›
Seeking Alpha·Positive

BioMarin: Better Risk-Reward Ahead Of Three FDA Decisions

BioMarin is a speculative Buy as lower valuation, FDA catalysts, and Voxzogo growth potential may reward long-term investors. Click to read more on BMRN stock. - BioMarin’s lower valuation and broader commercial portfolio now offer a…

@PRNewswire·Positive

BioMarin to Participate in Upcoming Investor Conferences

PR Newswire - Stifel Healthcare Conference, November 11 at 3:20 pm EST - UBS Global Biopharma Conference, November 16 at 9:20 am GMT - Jefferies Global Healthcare Conference, November 17 at 11:30 am GMT SAN RAFAEL, Calif., Nov. 4, 2026 /PRN

From the 4Search news index, newest first.

In the news

51mentions in 30 days
25with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 51 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance